vTv Therapeutics (VTVT) Tops Q1 EPS by 5c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• Sun Communities names Ileana McAlary as general counsel and EVP